These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6128086)

  • 21. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
    Glover DR; Wathen CG; Murray RG; Petch MC; Muir AL; Littler WA
    Br Heart J; 1985 Feb; 53(2):208-15. PubMed ID: 2857088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of nebivolol on left ventricular function in patients with chronic heart failure: a pilot study.
    Brehm BR; Wolf SC; Görner S; Buck-Müller N; Risler T
    Eur J Heart Fail; 2002 Dec; 4(6):757-63. PubMed ID: 12453547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial.
    Nelson HS; Gross NJ; Levine B; Kerwin EM; Rinehart M; Denis-Mize K;
    Clin Ther; 2007 Oct; 29(10):2167-78. PubMed ID: 18042473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
    Roubin GS; Choong CY; Devenish-Meares S; Sadick NN; Fletcher PJ; Kelly DT; Harris PJ
    Circulation; 1984 May; 69(5):955-62. PubMed ID: 6142775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of xamoterol in moderate cardiac insufficiency].
    Kayanakis JG; Larouchi L; Doat P; Grenet B; Fauvel JM; Bounhoure JP
    Presse Med; 1989 Apr; 18(13):667-70. PubMed ID: 2566161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
    Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
    J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
    Currie PJ; Kelly MJ; Middlebrook K; Federman J; Sainsbury E; Ashley J; Pitt A
    Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
    Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD
    Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle.
    Vigholt-Sørensen E; Faergeman O; Snow HM
    Br Heart J; 1989 Nov; 62(5):335-41. PubMed ID: 2574049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
    Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias.
    Canepa-Anson R; Dawson JR; Frankl WS; Kuan P; Sutton GC; Reuben S; Poole-Wilson PA
    Eur Heart J; 1982 Dec; 3 Suppl D():129-34. PubMed ID: 6130946
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective beta-1-adrenoceptor partial agonist treatment for congestive heart failure.
    Shabetai R
    Cardiology; 1990; 77(5):357-66. PubMed ID: 1981492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure.
    Kamalakkannan G; Petrilli CM; George I; LaManca J; McLaughlin BT; Shane E; Mancini DM; Maybaum S
    J Heart Lung Transplant; 2008 Apr; 27(4):457-61. PubMed ID: 18374884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Rae AP; Tweddel AC; Hutton I
    Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure.
    Virk SJ; Anfilogoff NH; Lawson N; Qiang F; Murray RG; Littler WA; Davies MK
    Eur Heart J; 1990 Oct; 11(10):876-84. PubMed ID: 1979946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of severe chronic CHF with oral pirbuterol.
    Awan NA; Needham K; Evenson MK; Mason DT
    Acta Med Scand Suppl; 1981; 652():155-62. PubMed ID: 6949462
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.